Citigroup Inc Nex Immune, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.3 - $0.6 $239,751 - $479,502	799,170 New	799,170 $303,000
Q2 2022 Aug 10, 2022	SELL	$1.61 - $4.68 $932 - $2,709	-579 Reduced 46.39%	669 $1,000
Q1 2022 May 12, 2022	SELL	$1.79 - $4.65 $5,880 - $15,275	-3,285 Reduced 72.47%	1,248 $5,000
Q4 2021 Feb 10, 2022	BUY	$4.11 - $15.13 $4,923 - $18,125	1,198 Added 35.92%	4,533 $21,000
Q3 2021 Nov 10, 2021	BUY	$10.32 - $16.9 $34,417 - $56,361	3,335 New	3,335 $50,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.